Monoamine oxidase B rs1799836 G allele polymorphism is a risk factor for early development of levodopa-induced dyskinesia in Parkinson's disease

BACKGROUND: Dopamine replacement therapy is an established treatment for motor symptoms of Parkinson's disease, but its long-term use is often limited by the eventual development of motor complications, including levodopa-induced dyskinesia. Genetic background, particularly polymorphisms of dop...

Descripción completa

Detalles Bibliográficos
Autores principales: Kakinuma, Shoko, Beppu, Minako, Sawai, Setsu, Nakayama, Akitoshi, Hirano, Shigeki, Yamanaka, Yoshitaka, Yamamoto, Tatsuya, Masafumi, Chigusa, Aisihaer, Xiamuxiya, Aersilan, Alimasi, Gao, Yue, Sato, Kenichi, Sakae, Itoga, Ishige, Takayuki, Nishimura, Motoi, Matsushita, Kazuyuki, Satoh, Mamoru, Nomura, Fumio, Kuwabara, Satoshi, Tanaka, Tomoaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183157/
https://www.ncbi.nlm.nih.gov/pubmed/32346620
http://dx.doi.org/10.1016/j.ensci.2020.100239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183157/
https://www.ncbi.nlm.nih.gov/pubmed/32346620
http://dx.doi.org/10.1016/j.ensci.2020.100239

Ejemplares similares